- Home
- RARE vs GT Comparison
RARE vs GT Comparison
Compare RARE & GT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- GT
- Stock Information
- Founded
- RARE 2010
- GT 1898
- Country
- RARE United States
- GT United States
- Employees
- RARE N/A
- GT N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- GT Automotive Aftermarket
- Sector
- RARE Health Care
- GT Consumer Discretionary
- Exchange
- RARE Nasdaq
- GT Nasdaq
- Market Cap
- RARE 3.5B
- GT 3.2B
- IPO Year
- RARE 2014
- GT N/A
- Fundamental
- Price
- RARE $36.68
- GT $10.72
- Analyst Decision
- RARE Strong Buy
- GT Strong Buy
- Analyst Count
- RARE 15
- GT 2
- Target Price
- RARE $90.53
- GT $15.00
- AVG Volume (30 Days)
- RARE 1.1M
- GT 6.2M
- Earning Date
- RARE 07-31-2025
- GT 07-30-2025
- Dividend Yield
- RARE N/A
- GT N/A
- EPS Growth
- RARE N/A
- GT N/A
- EPS
- RARE N/A
- GT 0.84
- Revenue
- RARE $590,689,000.00
- GT $18,594,000,000.00
- Revenue This Year
- RARE $18.94
- GT $0.29
- Revenue Next Year
- RARE $28.93
- GT $1.34
- P/E Ratio
- RARE N/A
- GT $12.26
- Revenue Growth
- RARE 33.46
- GT N/A
- 52 Week Low
- RARE $29.59
- GT $7.27
- 52 Week High
- RARE $60.37
- GT $12.58
- Technical
- Relative Strength Index (RSI)
- RARE 51.86
- GT 49.39
- Support Level
- RARE $36.03
- GT $10.26
- Resistance Level
- RARE $37.74
- GT $10.68
- Average True Range (ATR)
- RARE 1.46
- GT 0.44
- MACD
- RARE -0.01
- GT -0.06
- Stochastic Oscillator
- RARE 26.56
- GT 36.41
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About GT The Goodyear Tire & Rubber Company
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.